Beyond Chemical Imbalance: New Frontiers in Psychiatry with Dr. Theodore Henderson - #37
Beyond Chemical Imbalance: New Frontiers in Psychiatry with Dr. Theodore Henderson - #37
In this episode of the Neurostimulation Podcast, host Mike welcomes Dr. Theodore Henderson, a pioneering psychiatrist and neuroscientist whose work is reshaping the field of mental health. Dr. Henderson challenges the traditional "chemical imbalance" model of psychiatric disorders, advocating for a more nuanced understanding rooted in neuroimaging, neuroplasticity, and the biology of inflammation.
Key Topics Discussed:
- Dr. Henderson’s Journey: From a background in neurobiology and radiology to psychiatry, and how questioning the status quo led him to innovative treatments.
- Moving Beyond Chemical Imbalance: Why the serotonin hypothesis is outdated, and how new research points to neuroplasticity and mitochondrial health as central to mental wellness.
- Neuroimaging and Diagnosis: The role of SPECT scans in identifying brain dysfunction, traumatic brain injury, and differentiating between psychiatric conditions.
- Infrared Light Therapy (Photobiomodulation): How Dr. Henderson’s research has advanced the use of infrared light to stimulate brain repair, neuroplasticity, and recovery from conditions like depression, chronic fatigue syndrome, and traumatic brain injury.
- Ketamine and Synergistic Treatments: The science behind ketamine’s effects on neuroplasticity, and how combining it with infrared therapy can yield powerful results.
- Neuroinflammation and Viral Triggers: Insights into how chronic fatigue, depression, and even some cases of Parkinson’s and Alzheimer’s may be linked to viral infections and neuroinflammation.
- Long COVID: Dr. Henderson’s approach to treating long COVID symptoms, including fatigue and brain fog, with antiviral therapies and infrared light.
- Personalized Psychiatry: The importance of moving away from a “cookbook” approach to mental health, and embracing individualized, biomarker-driven diagnostics and treatments.
- Future Directions: The promise of next-generation transcranial magnetic stimulation (TMS), ongoing research collaborations, and the need for broader access to innovative therapies.
Actionable Insights:
- Clinicians: Consider neuroinflammatory and viral contributions to psychiatric symptoms; basic blood tests and antibody panels can be informative.
- Patients: There is hope beyond standard medications—emerging therapies may offer new avenues for recovery.
Resources:
- Dr. Henderson’s book: Brighter Days Ahead (link in show notes)
- Dr. Henderson’s clinic and contact information (link in show notes)
Connect with Dr. Henderson:
- https://neuro-luminance.com/about/
- https://neuro-luminance.com/brighter-days-ahead/
If you’re interested in the future of mental health treatment, from infrared laser therapy to the role of neuroinflammation, this episode is essential listening.
Transcript
Welcome back to the
Neurostimulation podcast.
2
:Today I'm joined by Dr.
3
:Theodore Henderson, a trailblazing
psychiatrist, and neuroscientist whose
4
:work is redefining how we understand
and treat brain disorders from
5
:depression to traumatic brain injury,
long COVID to chronic fatigue syndrome.
6
:Dr.
7
:Henderson has pioneered approaches
that challenge the outdated
8
:chemical imbalance model.
9
:His new book Brighter Days Ahead
offers hope grounded in neuroimaging,
10
:infrared light therapy, and ketamine.
11
:In this episode, we're gonna
dive into revolutionary
12
:treatments, neurobiology, and Dr.
13
:Henderson's own personal story
that fuels his mission to
14
:change lives and change minds.
15
:Dr.
16
:Henderson, thanks for joining us today.
17
:Thank you for having me, Michael.
18
:So maybe we can start
with the big picture.
19
:I was wondering perhaps you can introduce
yourself to the audience a little, tell
20
:us about your background and then maybe
help us to understand how do you see the
21
:field of psychiatry evolving away from the
legacy chemical imbalance type of model?
22
:All right.
23
:Yeah.
24
:I, I think a childhood of adversity taught
me to be suspicious of the status quo.
25
:And then I read Thomas Kuhn's
The Structure of Scientific
26
:Revolutions in college.
27
:It literally became my Bible.
28
:And so every situation, every paradigm
I looked at, I was suspicious of,
29
:and I questioned and I challenged it.
30
:That served me well as a graduate
student and getting my PhD and served
31
:me relatively well as a medical
student, although, the hierarchy
32
:of medicine expects you to be the
obedient servant in in residency.
33
:The, so I, I took all my
background in neurobiology and
34
:went into radiology initially.
35
:And spent about a year and a half
before I just couldn't stand it
36
:anymore and switched to psychiatry
and never regretted that switch.
37
:I think psychiatry allows me to really
make a difference in the world and really
38
:help people, which is always been my goal.
39
:The neuroimaging came back though
because I got involved in SPECT brain
40
:imaging which is a functional brain
scan that shows you what's working
41
:and what's not working in the brain.
42
:And in that role I kept having to
tell people, look, the scan shows
43
:you have a traumatic brain injury.
44
:We've got nothing to help you.
45
:Sorry, have a nice life.
46
:That was very frustrating to me
as a clinician and as a person.
47
:So when the opportunity came to get
involved in photobiomodulation, I
48
:leaped at the chance, but the very
first thing I did was say, okay, we
49
:gotta make this rigorously scientific.
50
:And that's how I arrived at this point of
using photobiomodulation that is infrared
51
:light as a treatment for the brain.
52
:And thinking about all, neurological
and psychiatric disorders is
53
:really being about insufficient
neuroplasticity and insufficient
54
:mitochondrial and neuronal health.
55
:That's probably enough.
56
:Oh yeah.
57
:No, I think that's a fantastic
introduction and it's so interesting
58
:because I think we're at an exciting
time now in the field because of, as
59
:you say, many different multimodal
kinds of approaches to management
60
:are almost by definition having to
become more available for people.
61
:Other reasons because legacy treatments,
particularly medications, are just
62
:disappointing for so many people.
63
:And other kinds of
options are sorely needed.
64
:Yeah, I'm, I'm curious.
65
:I think it's really interesting to hear
and perhaps, we can spend quite a bit
66
:of time talking about those particular.
67
:Kind of technologies and treatments
that you've just referred to, but I was
68
:also interested in what you've written
about and have content on in terms of
69
:depression and associated conditions,
like perhaps chronic fatigue syndrome
70
:as neuroinflammatory conditions.
71
:Perhaps maybe you could help
us to understand your thoughts
72
:around that kind of thing as well.
73
:Yeah.
74
:That's a really interesting story.
75
:Thank you for asking about that.
76
:It, that really again, came
from this work in neuroimaging.
77
:I have patients who are coming and
saying, they think they had a stroke.
78
:And a stroke looks very
characteristic on a brain scan.
79
:It's a.
80
:The vascular territory of the
involved artery is shut down,
81
:and I wasn't seeing that at all.
82
:In fact, what I was seeing was diffuse,
patchy dysfunction throughout the
83
:entire brain, and that raises a question
of, okay, this is something systemic.
84
:This is' localized.
85
:This is involving the whole brain.
86
:In fact, probably the whole body.
87
:So that led me to ask
the patients questions.
88
:And what came out was a a downward
trajectory of more and more fatigue and
89
:brain fog and concentration problems
and memory problems and errors at work.
90
:And that very much sounded
like chronic fatigue syndrome.
91
:Now, I had.
92
:I already had some brushes with
the interaction of certain viruses,
93
:in particular Epstein-Barr virus,
which is herpes four and herpes six
94
:with which is just called herpes
six in brain dysfunction in areas
95
:of autism and things like that.
96
:In my neuroimaging work.
97
:So as a clinician, then I started
researching what was out there
98
:and discovered a Martin Lerner's
pioneering work on treating chronic
99
:fatigue syndrome with antivirals
directed against those herpes viruses.
100
:So I started treating patients,
and here's the weird thing, not
101
:only did they, recover from the
fatigue and the brain fog, but
102
:their anxiety disorders went away.
103
:I started having patients who came
in with, saying, I'm depressed, doc.
104
:And okay what makes you
think you're depressed?
105
:I'm tired all the time.
106
:Oh, okay.
107
:So they had been diagnosed as
depression and put on SSRIs when
108
:in fact they had a viral infection.
109
:So I started curing depression by
treating them with an antiviral.
110
:So that sort of.
111
:Shift opened my eyes to, not
being stuck in a paradigm.
112
:If they say they're depressed or
somebody's told them they're depressed,
113
:maybe you need to ask more questions.
114
:And the fascinating thing is, I'm
now treated, four or 500 patients for
115
:chronic fatigue syndrome, and all sorts
of interesting things have happened.
116
:Their seizure disorders have gone away.
117
:That one always blows
away, neurologists away.
118
:I have patients who were diagnosed with
Parkinson's disease and after treating
119
:them their Parkinson's symptoms went away.
120
:And literally they go back
to the neurologist and the
121
:neurologist says I guess you
didn't have Parkinson's after all.
122
:So it's been remarkable to see, the
number of different disorders by symptom
123
:phenotype that turn out to actually
be the results of viral infections.
124
:Alzheimer's, again is a
great example of this.
125
:We could spend an hour
talking about Alzheimer's.
126
:Yeah, absolutely.
127
:Yeah.
128
:In particular with some recent
evidence that's really casting doubt
129
:on a lot of the underlying concepts
around pathophysiology of Alzheimer's.
130
:But I think just the fact that you
mentioned coon's structure of scientific
131
:revolutions at the beginning is really
interesting because I think part of
132
:what many psychiatrists struggle with,
particularly, mid or later career
133
:psychiatrist, is, working in the system
and becoming frustrated with, and
134
:maybe having some more insight into
how, the pharmac industrial regulatory
135
:kind of capture is part of what kind
of guides, training and then guides
136
:early practice and you feel a bit.
137
:Because clinical practice guidelines
are also part of, in a way, part of
138
:that capture and then what your peers
are doing is part of that capture.
139
:And you feel like if you want to
maybe explore ideas that are out of
140
:the box there's so many different
barriers that get in the way of that,
141
:and that the root of least resistance
is just to go along to get along.
142
:And that ends up causing
patients to, be on four or five.
143
:Different psychotropic medications at
the end of the day because, and they
144
:don't have, it's really sad in many
cases because they just don't have
145
:the opportunity to see someone like
you who thinks out of the box and
146
:might diagnose them with more of an
inflammatory condition that could in
147
:fact be curative as you're describing.
148
:Yeah.
149
:So it's very much that, that
paradigm and the chemical imbalance
150
:theory, that depression is about
serotonin that's been disproven.
151
:Four meta-analyses.
152
:The latest was published about two
years ago that prove that serotonin
153
:has nothing to do with mood.
154
:The fact that Prozac increases
serotonin, which it does in about
155
:an hour is a happy accident.
156
:Prozac really does as an antidepressant
is very poorly, very weekly.
157
:If you're lucky and Saturn happens to
be in retrograde and Capricorn, that you
158
:will get an antidepressant benefit because
it very weekly turns on neuroplasticity.
159
:Yeah, that's interesting.
160
:And then you add in factors like placebo
or expectation effects, and then, those
161
:more recent comparison meta-analyses and
RCTs are showing that often they don't
162
:separate out much from placebo effects.
163
:So there you go.
164
:Yes, exactly.
165
:Exactly.
166
:Yeah.
167
:So maybe I'm interested then, so could
you help us understand a bit about
168
:different technologies that people may not
be familiar with that could potentially
169
:help with conditions like depression?
170
:In particular, I'm wondering
about this infrared laser therapy,
171
:which sounds very interesting.
172
:Yes.
173
:So the infrared photobiomodulation story
goes back actually to the Soviet Union.
174
:So that's about 50 years ago.
175
:NASA played around with it for a
little bit and found that they could
176
:speed the wound healing of astronauts.
177
:So the astronauts had an infrared
device up on their vehicles,
178
:I guess is the best word.
179
:But Harvard and a few other places,
uniform Services Hospital, and university
180
:of Sydney really got invested in
understanding photobiomodulation.
181
:So really key work came out of
Harvard that showed that if you in,
182
:take a hundred mice, whack-a-mole in
the head with a machine that gives
183
:'em all the same traumatic brain
injury, treat 50 with infrared light.
184
:Those 50 that were treated get better.
185
:The lesion is smaller in the brain.
186
:There's evidence that BDNF brain
derived neurotrophic factors turned on.
187
:This is the driver of
neuroplasticity in the adult brain.
188
:And so there's evidence of increased
synapses, increased dendrites, and
189
:those little mice that had a brain
injury or up running around, like
190
:nothing ever happened to them.
191
:So that pioneering work and the same
kind of work was done in stroke.
192
:Showed that infrared light turns
on a system and that system
193
:involves first the mitochondria.
194
:So certain wavelengths of infrared
light, if it can get through the
195
:scalp and skull and reach the brain
cell, activates the mitochondria.
196
:I could go into all the science of
that, but let's just leave it at that.
197
:The mitochondria in turn produce
more energy, but they also send
198
:signals down to the chromosomes
saying, turn on these genes.
199
:And so one of those genes is brain derived
neurotrophic factor, but there are several
200
:growth factors turned on depending on the
cell type as well as anti-inflammatory.
201
:Factors.
202
:So the infrared light is
actually activating brain cell
203
:repair and neuroplasticity.
204
:Now the problem is that the
skull of a mouse is about the
205
:thickness of six sheets of paper.
206
:So a half watt LED can
shine infrared light.
207
:Through that, we have much thicker skulls,
mine, thicker than most, and then our
208
:scalp is a good six millimeters thick.
209
:And a half lot LED doesn't even penetrate
one millimeter through human skin.
210
:So an LED is not gonna get
through the scalp and it and the
211
:skull and get into the brain.
212
:That's the problem with all these
LED devices that you can buy.
213
:You can go and spend $4,000, or you
can spend $27 on Amazon and get an
214
:LED infrared light device that you
can stick on your head and pretend
215
:that you're treating your brain.
216
:And I say pretend 'cause it's not
getting through the scalp and skull.
217
:Now there is a skin effect.
218
:Something in the skin gets activated,
which has benefit to the entire body.
219
:Treating the skin will speed,
wound healing throughout the body
220
:helps the brain a little bit.
221
:But the problem is, it's transient.
222
:If you don't keep doing those LED
treatments every day, as soon as
223
:you stop, the benefit goes away.
224
:Now contrast that with what we do.
225
:We went into the lab and figured out how
to get through the scalp and skull and
226
:three centimeters into the brain safely,
and deliver the right amount of energy to
227
:those neurons to turn on the mitochondria.
228
:That took us about a year and a half in
the research lab involving sheep heads,
229
:cadaver heads, living tissue, to sort
out those penetration parameters, and we
230
:applied those parameters then to people.
231
:And we have the, we first were treating
traumatic brain injury, so we had brain
232
:scans on them before and after treatment.
233
:And the changes were dramatic and not
only what you could see on the scan,
234
:but in these people's lives, right?
235
:Yeah.
236
:Yeah.
237
:That's amazing.
238
:It's really, yeah.
239
:Very interesting.
240
:And this idea about the
neuroplasticity in the BDNF.
241
:Induced therapeutic changes.
242
:It's really interesting how there's
a confluence that seems to be
243
:a unifying factor that's common
to the infrared laser therapy.
244
:The ketamine, as you say, to a small
extent, SSRIs, maybe can you help
245
:us understand, for example, like
with ketamine then as another option
246
:to improve neuroplasticity and how
that seems to really correlate.
247
:Not only correlate, but cause
improvements in conditions like
248
:the depression and chronic fatigue.
249
:Yeah.
250
:Great question.
251
:Thank you.
252
:So ketamine activates BDNF by a separate
mechanism and it does very powerful
253
:and through a series of molecular
steps, it actually turns on both
254
:ketamine and the receptor for ketamine.
255
:So there's more stuff and
more receptors for the stuff.
256
:So that.
257
:Boost neuroplasticity.
258
:Now, one of the things that I
recognized pretty early on was
259
:what if we put the two together?
260
:Infrared light turns on BDNF by
a mitochondrial mechanism, and
261
:ketamine turns it on by a different
mechanism through the NMDA receptor.
262
:And in fact, you get synergy, you get
one plus one equals three, not two.
263
:And in fact, we patented that.
264
:Synergistic combination and in
doing that work, for example,
265
:I'll just give you one example.
266
:It's impossible to do the study where
treat someone with infrared light.
267
:You go back in time, you treat them
with ketamine, you go back in time,
268
:and then you treat them with both and
see, which you can't do that right
269
:time machines only have one chair.
270
:The.
271
:Best analogy I can give you is that,
some of the patients that we treat
272
:with both ketamine and infrared
light, their brain scan showed really
273
:robust improvement in brain functions.
274
:Our depression patients who were
severely depressed, and we combine
275
:ketamine with infrared light therapy.
276
:Just, I had a psychiatrist call
me up and said, what the blankety
277
:blanket did you do to this lady?
278
:She looks fantastic.
279
:So it's a very robust change.
280
:There are other modalities that
may have that same synergy.
281
:Yeah, exactly.
282
:And I think before we
started, you have mentioned.
283
:Neuromodulation techniques, like the
transcranial magnetic stimulation.
284
:And so I guess that would be an example
of some of those other technologies
285
:yet that I suppose could continue
to act even more synergistically.
286
:And it's interesting.
287
:Because it strikes me that what
we're talking about really leads
288
:to discussion as to how all of this
is creating a sorely needed kind of
289
:environment where there's more of a
personalized approach to improving.
290
:Mental health as opposed to the cookbook
approach that is, like I said before, has
291
:disappointed so many people for so long.
292
:That's a great point.
293
:That's a great point.
294
:Yeah.
295
:The neuroimaging work that I've done
using functional brain scans or spec
296
:scans it's been frustrating because
number one, science, psychiatry, and
297
:neurologist just completely rejects.
298
:SPEC scans.
299
:It's been a fight and I actually wrote an
article with Dan Pave about two years ago
300
:called The Legacy of the TAs and Report.
301
:And the Tasman report was Neurology's
initial assessment of spec scans
302
:25 years ago in which they said
all these things are useless.
303
:The spec scans of 25 years
ago look like a RAR shock.
304
:They look like an ink block.
305
:They didn't look like a brain scan.
306
:And now we have brain scans.
307
:I can see details, I can see the
Klaus Strumm, I can see the putamen.
308
:I can see the, all the little brain
structures I can see in a spec scan now
309
:with the quality scans that we have.
310
:And so you would think we'd be using
those in psychiatry because it helps
311
:us to craft our treatment better.
312
:No, not at all.
313
:No.
314
:Yeah, it's unfortunate, and I mean
it, I hate to sound conspiratorial,
315
:but one, one, there's really hardly
any other conclusions when you
316
:think about things like, why are
there such a dearth of biomarker
317
:driven diagnostics in psychiatry?
318
:Even something as.
319
:As traditional, or some might say outdated
as the dexamethasone suppression test.
320
:I remember mentors when I was in
training who were very smart people
321
:who said that actually the DST
is quite a reasonable biomarker
322
:diagnostic to add into the mix with.
323
:Any kind of clinical diagnosis of a major
depressive episode, yet we don't use it.
324
:And I think, I wonder if a lot of that
is just because again that there's
325
:capture of the journals with the
pharmacoeconomic complex and the drug
326
:companies aren't really interested
in having tests available that might
327
:rule out depression and decrease
their, the number of people that might
328
:be candidates for the treatments.
329
:Yeah.
330
:And bipolar one most often presents
initially with a depressive episode,
331
:and the dexamethasone suppression test
would differentiate bipolar one from.
332
:Major depressive disorder from unipolar
depression and prevent, maybe ever a
333
:manic episode or you start treating
the bipolar disorder appropriately.
334
:Same thing with brain spec scans.
335
:About three years ago I published
with colleagues in Mary McClain and
336
:a few others in Canada a series A,
a family who have bipolar disorder,
337
:and they all got variant spec scans
and their brains are identical.
338
:Absolutely identical.
339
:They all have the same bipolar marker
features of increased asymmetrical
340
:thalamic activity and asymmetrical,
increased cortical activity.
341
:If we did a spec scan on unipolar
depression, then yeah, we would
342
:pick up those bipolar cases before
they became, severely manic.
343
:And, the savings in, the
economics just for the.
344
:For the patient, not losing their
job with a manic episode, having
345
:a worse course because they were
put on an antidepressant initially.
346
:All of those things could be
prevented if we use biomarkers.
347
:Yeah.
348
:And spec is relatively available.
349
:Even up here in Canada where, we have our
default I'm a little bit embarrassed to
350
:say, our default for neuroimaging in on
the geriatric side where I'm spending most
351
:of my time is still cranial CT scanning.
352
:So even in our environment,
SPECT is relatively available.
353
:And as again, in the geriatric
population to help differentiate.
354
:Certain kinds of dementias, it
can be obviously quite helpful.
355
:But we don't really think, I don't have
a large, younger or middle age adult
356
:practice, but I think with colleagues,
I don't think many of them would ever
357
:think about ordering a spec scan, but I
can see why there would be a lot of value
358
:in that on the diagnostic side for sure.
359
:Yeah.
360
:Yeah.
361
:And we could talk about Alzheimer's
and the Alzheimer's imaging
362
:and, spective is more valuable
than say even a amyloid scan.
363
:So again, you're right.
364
:That's this engine that drives
things and nuclear medicine and
365
:radiologists wanna do amyloid scans.
366
:Yeah.
367
:Yeah, it's interesting.
368
:And I think, yeah, even more
interesting because of all the recent
369
:concern that's coming out regarding
the potential that the whole amyloid
370
:hypothesis for Alzheimer's might be.
371
:Somewhat or perhaps
completely off the mark.
372
:So what does that mean
for the whole approach?
373
:Yeah, it's really interesting.
374
:How about the long COVID syndrome?
375
:Everyone you know is still concerned
about the legacy of COVID, obviously.
376
:It was a huge, a very
impactful time for everyone.
377
:Very disruptive for all kinds
of reasons and many folks are
378
:left with this long COVID.
379
:So I really don't know too much about
it, but it strikes me as interesting
380
:in terms of the potential overlap with.
381
:Something like chronic fatigue syndrome
and the neuroinflammatory component.
382
:Do you mind helping us to understand
a little bit more about your work with
383
:long COVID patients and how that ties
in with what we've been talking about?
384
:I'd be happy to.
385
:I just gave a presentation at the
World Brain Mapping Conference
386
:in Los Angeles a few months ago,
and so this is fresh in my head.
387
:The estimates are that about
30% of people who got COVID will
388
:develop long COVID symptoms.
389
:And long COVID symptoms are
fatigue, brain fog memory problems,
390
:sometimes neurological symptoms
like ticks or tremors and also
391
:gastrointestinal symptoms.
392
:And then a lot of patients will
have persistent pulmonary symptoms,
393
:shortness of breath, et cetera.
394
:The theory is about COVID along
COVID, excuse me, are that number
395
:one, maybe there's fragments of the
spike protein left over floating
396
:around in the brain or the lungs.
397
:Another theory is that there are
micro clots throughout the tissues.
398
:I think that.
399
:Is less likely.
400
:But the most prominent theories
and the strongest theories are
401
:number one, that there's persistent
inflammation in the tissues.
402
:In fact, I've had three of my own
psychiatry patients who went to the
403
:local pulmonary hospital and had lung
biopsies 'cause of their shortness
404
:of breath and chest pain, and they
were told, oh, we found inflammation.
405
:We don't know what it is, and we
don't know what to do about it.
406
:That's how big inflammation
is a part of this.
407
:So inflammation in the brain as well.
408
:The second prominent theory
is that long COVID, because of
409
:the cytokine storm, induces a
reactivation of latent infections
410
:such as Epstein-Barr or Herpes six.
411
:Now not everybody has,
or herpes six despite.
412
:Medicines claim that's the case.
413
:It's really in my hands.
414
:It's about 60% of patients that I
have tested have Epstein-Barr and
415
:about 55 to 58% have herpes six.
416
:The third theory is there's reactivation
of latent bacterial infections
417
:such as Lyme disease, Bartonella.
418
:In treating these patients, number
one, I always go looking for the
419
:Epstein-Barr evidence and if that's
there, I'm treating them with antivirals.
420
:But, we're typically treating
the patients with infrared light
421
:and around about treatment 10
their fatigue begins to improve.
422
:And around about 1415, their cognitive
function is back to baseline.
423
:I'll give you just one example.
424
:So a dentist came up from Florida.
425
:And he had been sidelined by the
fatigue and the brain fog, and he
426
:had developed a tremor, not good
for a dentist to have a tremor.
427
:And he had tried everything.
428
:He had tried hyperbarics, he
had tried various infusions.
429
:He had tried ozone therapy.
430
:So he came to us pretty desperate
and having spent a ton of money on
431
:all these other failed therapies.
432
:He had 20 treatments,
roundabout treatment.
433
:14.
434
:He pulls me aside and
says, doc, this is weird.
435
:I've taken Vyvanse a
stimulant my whole life.
436
:'cause I have a DHD and
now it makes me jittery.
437
:So I stopped taking it.
438
:And Doc, I can concentrate just.
439
:And so he, not only did his fatigue
go away, his mental clarity came back.
440
:His energy, was through the roof.
441
:He was doing fantastic.
442
:His tremor gone and he
no longer had a DHD.
443
:So he stopped taking his Vyvanse.
444
:He stopped needing to take Xanax at
night 'cause he was so much less anxious
445
:and he went back and he is working it's
now two and a half, three years out.
446
:I communicate with him every six months.
447
:He continues to do fantastic
and he doesn't need a stimulant.
448
:Yeah, that's fantastic.
449
:That must be so rewarding to be able to
help folks like that, who've just had
450
:so much frustration with other options.
451
:That is one of my core values, is
I wanna bring hope to patients.
452
:They're told all the time, oh,
there's nothing you can do about it.
453
:And that frustrates me.
454
:Yeah I think I'm wondering, just
in terms of what any clinicians who
455
:are listening might be able to start
doing in their daily practice to
456
:start thinking more about this and
incorporating some of these ideas.
457
:Are there some basic blood tests?
458
:I guess it's difficult to say
specifically, but in general, are
459
:there, is there a basic approach to
the workup for becoming more suspicious
460
:about a neuroinflammatory kind of
contribution to mental illness?
461
:Yeah, there is.
462
:There is and I'm happy to share it.
463
:And in fact, if there's a clinician
out there who wants help with,
464
:getting started doing this treatment,
'cause I don't own this is.
465
:Dr.
466
:Lerner's work.
467
:I'm just championing it.
468
:So I'm happy to be a consultant
for people who need that.
469
:So basically, I look at antibody
titers for the herpes viruses.
470
:So I, I check herpes one two
just because I like that metric.
471
:And herpes one is
important in Alzheimer's.
472
:Herpes three is varicella, and
that's, again, it's a good kind of.
473
:Landmark 'cause most people
have had varicella and therefore
474
:they'll have antibodies.
475
:And what you'll find is their
antibody levels are really low.
476
:If they've.
477
:If they have active Epstein-Barr virus,
their antibody levels will be very high.
478
:So for Epstein-Barr, there's a viral coat
antigen and there's a nuclear antigen.
479
:And then there's also what's called
the early antigen, and that's the
480
:piece of the protein coat that goes
in and takes over the DNA machinery.
481
:So it's important to look at that.
482
:I check herpes five 'cause it's, I
see that as a very small fragment
483
:of my chronic fatigue patients.
484
:So cytomegalovirus.
485
:And then herpes six.
486
:The rest they get more expensive
'cause they're uncommon.
487
:So seven and eight are genetic variants
of herpes six and 9, 10, 11, 12
488
:are only known from brain biopsies.
489
:So I often offer my patients,
Hey, I'm happy to go get my drill.
490
:They generally turn me down as rest of
the rest of the lab workup a, C, B, C.
491
:So then, and then you do a
lymphocyte subset pro profile.
492
:That allows you to look at
the natural killer cells and
493
:CD four and CD eight cells.
494
:If they can afford it a cytokine
panel but generally they cannot.
495
:So then just do a TGF beta.
496
:It's much less expensive and it's
the best marker right now for
497
:lung, for chronic fatigue syndrome
and pretty good for long COVID.
498
:I also do a C-reactive protein.
499
:And then I check a creatinine and a liver
function because I'm gonna be putting them
500
:on a antiviral, which rarely, and let me
emphasize, rarely, like twice in my career
501
:has anybody had any kinda liver problems
from the antivirals that I'm using.
502
:Yeah.
503
:No, that's fantastic.
504
:Really appreciate that.
505
:Yeah.
506
:Just for viewers and listeners,
I'm gonna put links to Dr.
507
:Henderson's content and contact
information in his clinic and the
508
:book as well in the show notes.
509
:So I'd really encourage
people to check that out.
510
:Maybe just since we but I
referred to your book right there.
511
:Maybe you can tell us a little bit
about that and the story behind
512
:the book and what you're hoping
to accomplish by writing that.
513
:And the book evolved as I wrote it.
514
:You rewrite books like five or six times.
515
:And what it came to be was my attempt
to help people rethink depression.
516
:And so I use Ketamine as a model,
but it's not just about ketamine.
517
:But I think the way that
Ketamine is administered at
518
:least in the US is BA wards.
519
:The standard protocol is six
infusions in two weeks, and
520
:where that protocol came from.
521
:So it, it basically came from the
early studies and I actually asked
522
:one of the investigators in one of
the early studies why they did six
523
:infusions in two weeks, and his response
was quite literally, I don't know,
524
:it sounded good that's the science.
525
:So there is no justification for it.
526
:In fact, there's a counter.
527
:Justification for doing six infusions in
two weeks, and that is neuroplasticity.
528
:You're not gonna make neuroplasticity
happen any faster by having somebody
529
:get an infusion every other day.
530
:In fact, in my clinic, I never do
infusions more than once a week, and now
531
:most of the time it's every two weeks.
532
:And so by giving neuroplasticity
time to work, my patients get
533
:better with four infusions.
534
:So it's, and my response rate
is a 78% response rate, and
535
:the national average is 51 52.
536
:So by giving time people spend
less money, get less ketamine
537
:and have a better outcome.
538
:I kept telling that story and I kept
telling horror stories of how other
539
:ketamine clinics had given people giant
doses and then left them in the hallway.
540
:And I said, I need to just
write the book because I keep
541
:saying the same thing to people.
542
:And so that was where the book originally
came from, is I kept finding myself
543
:explaining the same thing over and over.
544
:But I think the book, most
importantly, the book gives hope.
545
:There's lots of stories of patients
and even patients who failed
546
:to get better with ketamine.
547
:And that's what leads me to help
people understand there's more to
548
:depression than just chemical imbalance.
549
:Yeah.
550
:Fantastic.
551
:Yeah, I really appreciate that.
552
:I appreciate the message of hope
because it is we've been saying a few
553
:times today already that historically
there's just such a frustration, I
554
:think, with clinicians and patients.
555
:And patients are often left
feeling hopeless because after
556
:years, maybe even decades of.
557
:Or partially effective treatments,
they still have suffering, they
558
:still have functional impairments.
559
:So hopefully with all these other
kinds of options and people can
560
:continue to just try to maintain hope
that they'll find something, some
561
:combination of treatments that ends
up working better for yeah, exactly.
562
:So yeah.
563
:Based on that and your experience
with all these innovative
564
:therapies, what would you say is.
565
:Perhaps the one of the biggest or
a couple of the biggest potential
566
:opportunities for improvements and
positive changes in mental health
567
:care over the next five to 10 years.
568
:Certainly one is the adoption
of infrared photobiomodulation,
569
:particularly if they're using a multi
watt protocol such as what we do.
570
:I think that will, would revolutionize
brain health across the spectrum.
571
:One of the things we haven't talked
about is certain waveless lakes of
572
:infrared light actually speed the
clearance of toxins from the brain.
573
:So you want less amyloid in your brain.
574
:You'll want less alcohol
induced toxins in your brain.
575
:You want less age related
toxins in your brain.
576
:Infrared light.
577
:The other is this
revolution that's happening.
578
:The next generation of transcranial
magnetic stimulation devices
579
:have emerged and these devices
have much more powerful magnets.
580
:They're close to, literally an MRI.
581
:In terms of their magnetic field.
582
:And it, number one, speeds the treatment.
583
:So treatment is reduced from 40
hour long treatments every day of
584
:the week down to six treatments
lasting 20 some odd minutes.
585
:So that revolution and TMS interestingly,
TMS turns on neuroplasticity.
586
:And activates BDNF by
yet a third mechanism.
587
:So what we're exploring now in
the clinic, and I'm super excited
588
:about, is the synergy that could
occur between infrared light and
589
:transcranial magnetic stimulation
in particular areas of the brain.
590
:Yeah, know.
591
:That's amazing.
592
:So it's really interesting to think
about you can all these synergistic start
593
:to add up, exactly as you're saying.
594
:You combine that perhaps even with
ketamine and then just even the positive
595
:therapeutic relationship and that's it's
in some ways, it's really not surprising
596
:that you're getting such excellent
results, so congratulations for that.
597
:Thank you.
598
:Thank you.
599
:Yeah.
600
:That's great.
601
:So I guess I'm curious, 'cause you have
mentioned some of your research endeavors
602
:what would be, some future ideas or
some hopes plans for collaboration or
603
:research projects over the next few years?
604
:Great question.
605
:Very timely too.
606
:I've had a long relationship with
Harvard and we're a group of scientists.
607
:There are under Paula Cassano
and I are working on a grant.
608
:And this is looking at comparing
the low power infrared light, the
609
:LEDs that you can buy and stick
on your head at home versus the
610
:multi watt protocol with controls.
611
:And the grant that we're preparing
to submit is going to the va.
612
:So it'd be looking at traumatic
brain injury in veterans.
613
:And, the veteran population
is so important and un
614
:underappreciated, at least in the us.
615
:And every day, the same number
of veterans could die by suicide.
616
:In 2025, as was true in 2017 no
progress has been made for them.
617
:And so when I look at, the power
of ketamine, the power of multi
618
:wat infrared light, and the
power of these next generation
619
:transcranial magnetic stimulation
devices such as the Exide to help.
620
:It's just mind boggling to me why we're
not treating veterans aggressively
621
:with these type of modalities rather
than pills and, group therapy.
622
:Yeah.
623
:Particularly the traumatic brain
injury or the PTSD kinds of issues
624
:that are so common in veterans.
625
:Yeah.
626
:Yeah, exactly.
627
:Yeah.
628
:For sure.
629
:I really appreciate it.
630
:Before we wrap up, is there anything
else that you wanted to bring up Dr.
631
:Anderson?
632
:The only thing I would say is that, this.
633
:I've got one clinic in Denver.
634
:This should be all over the country.
635
:So if any listeners out there
are interested in investing
636
:in, the next generation in
healthcare give me a ring and.
637
:I'm happy to talk about it.
638
:A research study such as looking
at PTSD or looking at Parkinson's
639
:or looking at Alzheimer's,
costs about three, $4 million.
640
:And the grants are difficult
to get because, we're not.
641
:University.
642
:And moving forward moving the field
forward is a slow, laborious process.
643
:The PO potential for helping
people across North America.
644
:I'd be happy to have a clinic
in Canada and we've explored
645
:that with my colleagues.
646
:It will also take capital.
647
:Yep.
648
:Definitely.
649
:Kudos for all your efforts, and
again, I'm just it's so exciting
650
:and heartwarming to hear about
all the folks that you're helping.
651
:So thanks again for a great discussion.
652
:Absolutely.
653
:And yeah, I just wish you all the
best and maybe we can have a coffee
654
:sometime in an upcoming conference.
655
:That'd be great.
656
:Excellent.
657
:Okay.
658
:That's great.
659
:So that was our conversation with Dr.
660
:Theodore Henderson, who's pushing
the boundaries of what's possible
661
:in psychiatry and mental healthcare
with evidence and empathy.
662
:If you are curious about treatment
options like infrared laser if you're
663
:curious about how neuroinflammation is
implicated in various disorders like
664
:depression, chronic fatigue, long COVID.
665
:Or if you're curious about how the future
of mental health treatment may well
666
:involve light instead of just pills.
667
:His work is really essential
reading, and I'd encourage all of
668
:the original listeners to check
out his book Brighter Days Ahead.
669
:Again, I'm gonna put links
to where you can find Dr.
670
:Henderson's content in the show notes.
671
:Once again, Dr.
672
:Henderson, thanks so much for joining
us and just wish you all the best.
673
:Thank you so much for having me.
674
:My pleasure.
675
:Okay, have a great day.
676
:See you later.
677
:Thank you.
678
:Bye-bye.
